Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension
Corporación Bonima S.A. de C.V.
Bayer

      A single dose, two treatments (two cephalexin suspension brands), two sequences, cross-over
      design was used with a washout of 7 days between the two study periods. Treatment groups
      balanced with the same number of healthy volunteers who were randomly (in two strata: male
      and female) assigned to the study drug administration sequences.
    
Drug